Education Information: Cardiff achieves ‘Champion’ status for gender equality in physics  |  Parent Interventions: Online survey to assess needs of children and young people with cancer   |  Parent Interventions: Study links severe childhood deprivation to difficulties in adulthood  |  Parent Interventions: New study aims to learn the lessons of homeschooling  |  Teacher Insights: Using e-learning to raise biosecurity awareness  |  National Edu News: Science and Technology in finding solutions to combat COVID-19  |  National Edu News: Ek Bharat Shreshtha Bharat programme  |  Health Monitor: Beware of Hepatitis D, It can Lead to Hepatocellular Carcinoma  |  Teacher Insights: Education project to understand Birmingham learning at home during COVID-19  |  Education Information: UoG launches new onlines to meet some of the challenges of Covid-19  |  Teacher Insights: Professor Woolfson awarded Humboldt Research Prize  |  Parent Interventions: Parents paying heavy price for lockdown  |  Teacher Insights: Great Science Share brings science investigations into homes  |  Education Information: App will reduce high risk of falls during and after Lockdown  |  Education Information: University of Manchester to decarbonise its investment portfolio  |  
May 20, 2020 Wednesday 07:06:36 PM IST

Agappe Chitra Magna for detection of Covid-19

Leadership Instincts

The commercial launch of,  Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit for use during testing for detection of COVID-19 developed by Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) - Trivandrum, an Institute of National Importance of the Department of Science and Technology (DST) along with Agappe Diagnostics Ltd, an in vitro diagnostics manufacturing company based in Cochin is being organized tomorrow. The launch programme is being organized by SCTIMST in collaboration with Agappe Diagnostics Ltd at the Biomedical Technology Wing of SCTIMST.

Inexpensive, fast, and accurate testing for COVID-19 virus is the cornerstone of containing its spread and providing appropriate help to the infected.The Chitra Magna, an innovative RNA extraction kit developed by SCTIMST under the leadership of senior scientist, Dr. Anoopkumar Thekkuveettil, was transferred to Agappe Diagnostics in April 2020, and will now be available in the market as Agappe Chitra Magna RNA Isolation Kit. This product has been independently validated at National Institute of Virology for Covid19 RNA isolation. Central Drugs Standard Control Organisation (CDSCO) has given approval for the commercialization of this kit. The kit can be used for RNA extraction for RT-LAMP, RT-qPCR, RT-PCR and other isothermal and PCR based protocols for the detection of SARS-COV-2. 

It uses innovative technology for isolating RNA using magnetic nanoparticles to capture the RNA from the patient sample. The magnetic nanoparticle beads bind to the viral RNA and, when exposed to a magnetic field, give a highly purified and concentrated RNA. As the sensitivity of the detection method is dependent on getting an adequate quantity of viral RNA, this innovation enhances the chances of identifying positive cases.

It is estimated that India would require about 8 lakh RNA extraction kits per month during the next six months, and Agappe Chitra Magna RNA Isolation Kit priced around Rs. 150 per kit is expected to reduce the cost of testing and the country’s dependence on imported kits which cost around Rs 300. Agappe Diagnostics has a manufacturing capacity of 3 lakh kits per month. 


Comments